Last reviewed · How we verify
Formoterol Fumarate DPI
Formoterol Fumarate DPI is a Small molecule drug developed by Organon and Co. It is currently in Phase 2 development. Also known as: SCH 045571, MK-5571, Foradil® Aerolizer®.
At a glance
| Generic name | Formoterol Fumarate DPI |
|---|---|
| Also known as | SCH 045571, MK-5571, Foradil® Aerolizer® |
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- VENTURI (VENTilation Using Respiratory Imaging) (PHASE2)
- Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler (NA)
- Anti-Inflammatory Reliever South Africa (PHASE3)
- Respiratory and Peripheral Muscle Strength as Predictors of Inhaler Treatment Response in Asthma: A Comparison of DPI and MDI Devices (NA)
- Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators (PHASE4)
- A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) (PHASE2)
- Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) (PHASE3)
- Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Formoterol Fumarate DPI CI brief — competitive landscape report
- Formoterol Fumarate DPI updates RSS · CI watch RSS
- Organon and Co portfolio CI
Frequently asked questions about Formoterol Fumarate DPI
What is Formoterol Fumarate DPI?
Formoterol Fumarate DPI is a Small molecule drug developed by Organon and Co.
Who makes Formoterol Fumarate DPI?
Formoterol Fumarate DPI is developed by Organon and Co (see full Organon and Co pipeline at /company/organon-and-co).
Is Formoterol Fumarate DPI also known as anything else?
Formoterol Fumarate DPI is also known as SCH 045571, MK-5571, Foradil® Aerolizer®.
What development phase is Formoterol Fumarate DPI in?
Formoterol Fumarate DPI is in Phase 2.
Related
- Manufacturer: Organon and Co — full pipeline
- Also known as: SCH 045571, MK-5571, Foradil® Aerolizer®
- Compare: Formoterol Fumarate DPI vs similar drugs
- Pricing: Formoterol Fumarate DPI cost, discount & access